Literature DB >> 19025852

Development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials.

P Coplan1, L Chiacchierini, A Nikas, J Shea, A Baumritter, K Beutner, W Cassidy, M Sawyer, B Watson, J Heyse, H Guess.   

Abstract

In vaccine trials, diary questionnaires or vaccination report cards (VRCs) are used extensively to collect complaints reported by subjects or guardians following vaccination. These have not been evaluated for accuracy or standardized to facilitate tolerability comparisons among vaccines.Objectives -(1) Develop standardized, age-specific VRCs for collecting self-reported adverse events (AEs) in trials; (2) Evaluate whether complaints elicited by nurse examinations or telephone interviews were missed by VRCs.Methods -Vaccine-trial databases, focus groups, experts and experienced nurses were used to develop paediatric and adolescent/adult VRCs. VRCs were evaluated at four sites. The primary outcome was subjects with AEs missed on the VRC and reported in nurse examinations (for injection-site reactions) or telephone interviews (for systemic complaints).Results -Of 855 subjects, 96.5% completed VRCs. For systemic complaints, 1.5% (12/812) reported both no complaint on VRCs and at least one complaint in telephone interviews. For injection-site reactions, 5.1% (53/1030) of injection sites had both no reaction reported on VRCs and had reactions noted by nurse examination. No missed AEs were rated as severe.Conclusion -The data suggest VRCs provide a practical and reasonably complete method of eliciting complaints following vaccination. Copyright (c) 2000 John Wiley & Sons, Ltd.

Year:  2000        PMID: 19025852     DOI: 10.1002/1099-1557(200011)9:6<457::AID-PDS529>3.0.CO;2-R

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance.

Authors:  Josephine M Norquist; Shazia S Khawaja; Cizely Kurian; T Christopher Mast; Kai-Li Liaw; Michael N Robertson; Barbara Evans; David Gutsch; Patricia Saddier
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL).

Authors:  Zoran Popmihajlov; Lei Pang; Elizabeth Brown; Amita Joshi; Shu-Chih Su; Susan S Kaplan; English D Willis
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

Review 3.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 4.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

Review 6.  A Bayesian network meta-analysis: Comparing the clinical effectiveness of local corticosteroid injections using different treatment strategies for carpal tunnel syndrome.

Authors:  Po-Cheng Chen; Ching-Hui Chuang; Yu-Kang Tu; Chyi-Huey Bai; Chieh-Feng Chen; Mei- Yun Liaw
Journal:  BMC Musculoskelet Disord       Date:  2015-11-19       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.